MedTrace Logo

The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial

NCT06213714 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-01-19

No results posted yet for this study

Summary

The objective of this study is to examine the safety and effectiveness, from both clinical and technical perspectives, of utilizing the 5G-Robotic VRS100 system in percutaneous coronary intervention (PCI).

Conditions

Interventions

DEVICE

5G Tele-Robotic-Assisted PCI

The 5G Tele-Robotic-Assisted VRS100 system is intended for use in the remote delivery and manipulation of guidewires and rapid exchange balloon/stent catheters, and remote manipulation of guide catheters during percutaneous coronary intervention (PCI) procedures.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    collaborator OTHER

  • Kunming Chenggong District People's Hospital

    collaborator UNKNOWN

  • Yan'an Affiliated Hospital of Kunming Medical University

    lead OTHER

Principal Investigators

  • Junbo Ge · Shanghai Zhongshan Hospital

  • Chenguang Li · Shanghai Zhongshan Hospital

  • Qiang Xue · Yan'an Affiliated Hospital of Kunming Medical University

  • Wangxiong Li · Kunming Chenggong District People's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-29
Primary Completion
2024-06-30
Completion
2024-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213714 on ClinicalTrials.gov